Funder
NIH
Canadian Institutes of Health Research
Parkinson Study Group
Michael J. Fox Foundation
Pharma2B
National Parkinson Foundation (PPMI)
NINDS
MJFF
Northwestern Foundation
Civitas
Acorda
Biogen
Roche Neuroderm
NIH PCORI
Allergan
University Hospital Foundation
Chemical Heritage Foundation
Frankfurt/Main
German Ministry of Education and Health
IPF
National Parkinson Foundation
Accorda
Kyowa
US World Meds
Abbvie
Biotie/Acorda Therapeutics
Movement Disorders Society
NIH/NINDS
Rhythm
Sunovion
Zambon pharma
Zambon
UCB
Cynapsus
Sunovia
Chiesi
Britannia
Neuroderm
BIAL
Subject
Neurology (clinical),Geriatrics and Gerontology,Neurology
Reference75 articles.
1. “On-off” effects in patients with Parkinson's disease on chronic levodopa therapy;Marsden;Lancet,1976
2. Long-term side-effects of levodopa;Barbeau;Lancet,1971
3. The clinical physiology of side effects in long-term L-DOPA therapy;Barbeau;Adv. Neurol.,1974
4. Aromatic amino acids and modification of parkinsonism;Cotzias;N. Engl. J. Med.,1967
5. The “on-off” response to chronic L-DOPA treatment of Parkinsonism;Sweet;Adv. Neurol.,1974
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献